Parallel Advisors, LLC
- SEC CIK
- 0001690010
- Latest filing
- Aug 5, 2026
BBIO holding history
BridgeBio Pharma, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BBIO overviewAll 13F holders of BBIOFull Q2 2026 holdings
- Shares (Q2 2026)
- 843
- Value
- $62.8K
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 843 | $62.8K | <0.1% | −51−5.7% | Reduced | Holders |
| Q1 2026 | 894 | $66.4K | <0.1% | +757+552.6% | Added | Holders |
| Q4 2025 | 137 | $10.5K | <0.1% | +6+4.6% | Added | Holders |
| Q3 2025 | 131 | $6.80K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 131 | $5.66K | <0.1% | +10+8.3% | Added | Holders |
| Q1 2025 | 121 | $4.18K | <0.1% | −3−2.4% | Reduced | Holders |
| Q4 2024 | 124 | $3.40K | <0.1% | −317−71.9% | Reduced | Holders |
| Q3 2024 | 441 | $11.2K | <0.1% | +405+1,125.0% | Added | Holders |
| Q2 2024 | 36 | $912 | <0.1% | +36 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −28−100.0% | Sold out | Holders |
| Q3 2023 | 28 | $738 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 28 | $482 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 28 | $464 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 28 | $213 | <0.1% | +28 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −34−100.0% | Sold out | Holders |
| Q2 2022 | 34 | $0 | 0.0% | +34 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −121−100.0% | Sold out | Holders |
| Q4 2021 | 121 | $2.00K | <0.1% | −367−75.2% | Reduced | Holders |
| Q3 2021 | 488 | $23.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 488 | $30.0K | <0.1% | −545−52.8% | Reduced | Holders |
| Q1 2021 | 1,033 | $64.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.